AVAX Technologies, Inc. Share Price Other OTC
Equities
AVXT
US0534953056
Biotechnology & Medical Research
Sales 2009 | 399K 31.8M | Sales 2010 | 142K 11.35M | Capitalization | 6.29M 501M |
---|---|---|---|---|---|
Net income 2009 | -19M -1.51B | Net income 2010 | -12M -956M | EV / Sales 2009 | 69 x |
Net Debt 2009 | 3.23M 257M | Net Debt 2010 | 3.1M 247M | EV / Sales 2010 | 65.9 x |
P/E ratio 2009 |
-1.24
x | P/E ratio 2010 |
-1.03
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Adele Sommerfeld
CEO | Chief Executive Officer | - | 18/10/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew W. Dahl
CHM | Chairman | 79 | 31/08/99 |
Adele Sommerfeld
CEO | Chief Executive Officer | - | 18/10/15 |
Bruno Maruzzo
BRD | Director/Board Member | 71 | - |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |